Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Atropine sulfate |
Is a |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Atropine measurement |
Component |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Poisoning by atropine |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Accidental atropine poisoning |
Causative agent |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Intentional atropine poisoning |
Causative agent |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
forgiftning med atropin, uvist med hvilken hensigt |
Causative agent |
False |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine adverse reaction |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Allergy to atropine |
Causative agent |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Atropine overdose |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Accidental atropine overdose |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Intentional atropine overdose |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
overdosis af atropin, uvist med hvilken hensigt |
Causative agent |
False |
Atropine (substance) |
Inferred relationship |
Some |
1 |
methylatropinnitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Product containing atropine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
atropin øjenpræparater |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin 2 mg injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Product containing atropine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
morphinsulfat + atropinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Product containing atropine and pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
atropin/pralidoxim injektionsvæske, opløsning, to autoinjektorer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin + pralidoxim, opløsning, enkelt autoinjektor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin 2,1 mg + pralidoxim 600 mg, opløsning, enkelt autoinjektor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin 2 mg + pralidoxim 600 mg opløsning, to autoinjektorer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Atropine penalization therapy for amblyopia (procedure) |
Direct substance |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Intentional atropine poisoning |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine methonitrate (substance) |
Is a |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
|
Accidental poisoning by atropine |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Allergy to atropine |
Causative agent |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Some |
2 |
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Atropine methonitrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Atropine (substance) |
Inferred relationship |
Some |
|
Atropine sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Atropine (substance) |
Inferred relationship |
Some |
|
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Product containing atropine and diphenoxylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Product containing atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Atropine- and diphenoxylate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Product containing atropine and difenoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine- and difenoxin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Product containing atropine and edrophonium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Product containing only atropine and edrophonium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Product containing only atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Atropine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine and difenoxin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine and diphenoxylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Product containing only atropine and pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine and difenoxin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Product containing only atropine and diphenoxylate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Atropine and hyoscine and hyoscyamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
2 |
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Product containing only atropine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |
Atropine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Some |
1 |